In current buying and selling, shares of Arrowhead Prescribed drugs Inc (Image: ARWR) have crossed above the typical analyst 12-month goal value of $87.27, altering palms for $89.51/share. When a inventory reaches the goal an analyst has set, the analyst logically has two methods to react: dow
www.nasdaq.com
Arrowhead Prescribed drugs Reaches Analyst Goal Value
